Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for the Prevention of Poor Graft Function Following Allo-HSCT in MDS
NCT07888348Phase 2Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Oct 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in poor graft function (PGF), sponsored by Ruijin Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
anakinra
03
Conditions
poor graft function (PGF)
Beyond the preview
Go deeper on NCT07888348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07888348.